NATIXIS ADVISORS, L.P. - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,114 filers reported holding NOVARTIS A G in Q3 2020. The put-call ratio across all filers is 0.62 and the average weighting 0.3%.

Quarter-by-quarter ownership
NATIXIS ADVISORS, L.P. ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$94,513
+0.7%
927,857
-0.3%
0.29%
-0.3%
Q2 2023$93,887
+13.6%
930,410
+3.6%
0.29%
+2.1%
Q1 2023$82,630
-27.2%
898,152
-28.2%
0.28%
-33.8%
Q4 2022$113,546
-99.9%
1,251,603
-9.4%
0.43%
-3.4%
Q3 2022$105,027,000
-12.7%
1,381,746
-2.9%
0.44%
-16.1%
Q2 2022$120,335,000
-21.2%
1,423,580
-18.2%
0.53%
-9.1%
Q1 2022$152,748,000
+3.3%
1,740,726
+3.0%
0.58%
+3.0%
Q4 2021$147,885,000
-14.1%
1,690,703
-19.7%
0.56%
-20.2%
Q3 2021$172,125,000
+37.6%
2,104,742
+53.5%
0.71%
+21.2%
Q2 2021$125,079,000
+4.3%
1,370,883
-2.3%
0.58%
-6.7%
Q1 2021$119,975,000
-2.4%
1,403,558
+7.8%
0.63%
-11.6%
Q4 2020$122,943,000
+30.2%
1,301,938
+19.9%
0.71%
+19.2%
Q3 2020$94,461,000
-7.0%
1,086,252
-6.6%
0.59%
-11.9%
Q2 2020$101,554,000
+1.4%
1,162,754
-4.2%
0.67%
-17.4%
Q1 2020$100,119,000
-4.7%
1,214,308
+9.5%
0.82%
+10.1%
Q4 2019$105,054,000
+17.7%
1,109,452
+8.0%
0.74%
+4.7%
Q3 2019$89,261,000
-8.3%
1,027,176
-3.6%
0.71%
-10.9%
Q2 2019$97,340,000
+8.7%
1,066,043
+2.6%
0.80%
+1.4%
Q1 2019$89,545,000
-48.4%
1,039,410
-48.6%
0.78%
-8.4%
Q4 2018$173,384,000
+126.1%
2,020,566
+127.0%
0.86%
+26.8%
Q3 2018$76,683,000
-38.0%
890,013
-45.7%
0.68%
+14.2%
Q2 2018$123,720,000
+78.1%
1,637,844
+90.7%
0.59%
-13.8%
Q1 2018$69,456,000
-1.8%
859,072
+2.0%
0.69%
-4.7%
Q4 2017$70,735,000
-7.8%
842,501
-5.8%
0.72%
-11.2%
Q3 2017$76,751,000
-10.4%
894,032
-12.9%
0.81%
-12.6%
Q2 2017$85,706,000
+10.2%
1,026,796
-2.0%
0.93%
+7.7%
Q1 2017$77,805,000
+12.4%
1,047,598
+10.2%
0.86%
+3.6%
Q4 2016$69,238,000
-13.2%
950,551
-5.9%
0.83%
-19.5%
Q3 2016$79,730,000
+0.3%
1,009,744
+4.8%
1.03%
-6.0%
Q2 2016$79,468,000
+41.3%
963,143
+24.0%
1.10%
+30.5%
Q1 2016$56,255,000
+13.6%
776,559
+34.9%
0.84%
+3.7%
Q4 2015$49,527,000
-3.7%
575,642
+2.9%
0.81%
-9.0%
Q3 2015$51,417,000
+0.0%
559,375
+7.0%
0.89%
+2.2%
Q2 2015$51,410,000
+8.4%
522,779
+8.7%
0.87%
+4.8%
Q1 2015$47,434,000
+18.0%
481,022
+10.9%
0.83%
+10.8%
Q4 2014$40,190,000
+16.7%
433,741
+18.6%
0.75%
+8.8%
Q3 2014$34,429,000
-20.8%
365,757
-23.8%
0.69%
+10.9%
Q2 2014$43,457,000
+10.2%
480,016
+3.4%
0.62%
+2.6%
Q1 2014$39,450,000
-0.6%
464,013
-6.0%
0.61%
-6.5%
Q4 2013$39,678,000
-1.3%
493,620
-5.8%
0.65%
-12.3%
Q3 2013$40,196,000
+18.1%
523,997
+8.9%
0.74%
+9.1%
Q2 2013$34,036,000481,3450.68%
Other shareholders
NOVARTIS A G shareholders Q3 2020
NameSharesValueWeighting ↓
NEXTHERA CAPITAL LP 198,000$14,422,0008.45%
PRENTISS SMITH & CO INC 133,202$9,702,0005.92%
EXENCIAL WEALTH ADVISORS, LLC 178,313$12,988,0005.50%
MANAGED ASSET PORTFOLIOS, LLC 185,868$13,538,0005.33%
Osher Van de Voorde Investment Management 114,735$8,357,0004.59%
BROWN BROTHERS HARRIMAN & CO 10,971,272$799,147,0004.37%
PROFESSIONAL ADVISORY SERVICES INC 238,542$17,375,0004.04%
Elefante Mark B 4,579$333,0004.02%
COMPASS CAPITAL MANAGEMENT, INC 271,536$19,779,0003.69%
CGOV Asset Management 972,731$95,135,0003.51%
View complete list of NOVARTIS A G shareholders